Recombinant Mouse Anti-Staphylococcal enterotoxin B (SEB) Antibody (20B1) (CAT#: PABL-337)

Recombinant Mouse Antibody (20B1) is capable of binding to Staphylococcal enterotoxin B (SEB), expressed in Chinese Hamster Ovary cells (CHO).


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA

Figure 1 Combination efficacy enhances SEB neutralization in vitro.

Figure 1 Combination efficacy enhances SEB neutralization in vitro.

Inhibition of T-cell proliferation by SEB-specific mAbs 20B1, 14G8, and 6D3, individually at concentration of 5 μg or in different combinations of 2.5 μg each followed by SEB (25 nM). Proliferation was measured by ViaLight HS cell proliferation kit after 96 h.

Dutta, K., Varshney, A. K., Franklin, M. C., Goger, M., Wang, X., & Fries, B. C. (2015). Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies. Journal of Biological Chemistry, 290(11), 6715-6730.

Figure 2 Combination efficacy enhances SEB neutralization in vivo.

Figure 2 Combination efficacy enhances SEB neutralization in vivo.

Protection against SEBILS was tested in BALB/c mice (n = 10 per group) that were injected intraperitoneally with 20 μg of SEB and treated with mAb alone or in combination. Analysis of survival data was performed using Mantel-Cox Test. Mice treated with combination of mAbs 6D3 (500 μg) and 14G8 (500 μg) or 20B1 (50 μg) and 14G8 (50 μg) significantly survived, although monotherapy with the individual mAb was either nonprotective (mAb 14G8 at 500 μg dose and mAb 20B1 at 50 μg dose) or partially protective (mAb 6D3 at 500 μg dose).

Dutta, K., Varshney, A. K., Franklin, M. C., Goger, M., Wang, X., & Fries, B. C. (2015). Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies. Journal of Biological Chemistry, 290(11), 6715-6730.

Figure 3 Combination efficacy enhances clearance of SEB from body fluid.

Figure 3 Combination efficacy enhances clearance of SEB from body fluid.

A and B, mice (n = 5) were treated with mAb 20B1, mAb 14G8, and mAb 6D3 alone or in combination (500 μg) and challenged with SEB. ELISAs were performed to measure the SEB levels from sera at 6 h after SEB challenge. SEB level was higher in blood at 6 h in mice treated with mAb alone or in combination of mAb 14G8 and mAb 6D3. Higher SEB clearance was observed from sera of mice treated with combination of mAb 20B1 and mAb 14G8 group.

Dutta, K., Varshney, A. K., Franklin, M. C., Goger, M., Wang, X., & Fries, B. C. (2015). Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies. Journal of Biological Chemistry, 290(11), 6715-6730.

Figure 4 Combination efficacy enhances clearance of SEB from body fluid.

Figure 4 Combination efficacy enhances clearance of SEB from body fluid.

C and D, SEB internalization with mAbs 20B1, 14G8, and 6D3 alone or in combination by primary peritoneal macrophage was performed in FcR (FcRγ−/−/RIIB−/−) knockout mice and compared with WT C57/BL6 mice. E and F, SEB internalization with mAb 20B1, mAb 14G8, or mAb 6D3 alone or in combination by purified human neutrophils. The y axis shows residual SEB concentration from the supernatant.

Dutta, K., Varshney, A. K., Franklin, M. C., Goger, M., Wang, X., & Fries, B. C. (2015). Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies. Journal of Biological Chemistry, 290(11), 6715-6730.

Figure 5 Neutralization efficacy of mAb 20B1 on SEC-1 toxin.

Figure 5 Neutralization efficacy of mAb 20B1 on SEC-1 toxin.

A, sequence alignment of selected SEB residues to SEC1–3 and SSA. The 17 SEB residues involved in the binding with 20B1 are colored green. B, ELISA showing comparable binding of mAb 20B1 to SEB and SEC-1. mAb 20B1 failed to bind SEC 2–3 and SSA toxins. The experiment was performed in duplicate. Each point represents the mean value of duplicates, and bars represent the standard error derived from measurements in the same experiment. C, BALB/c mice (n = 10 per group) were treated with mAb 20B1 (500 μg) or PBS intraperitoneally (intraperitoneal) and challenged with 5 μg of SEB or SEC-1 and sensitized with 75 μg of LPS (intraperitoneal) 3 h post-toxin injection. Mice treated with mAb 20B1 showed 100% survival compared with PBS treatment.

Dutta, K., Varshney, A. K., Franklin, M. C., Goger, M., Wang, X., & Fries, B. C. (2015). Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies. Journal of Biological Chemistry, 290(11), 6715-6730.


Specifications

  • Immunogen
  • S. aureus Staphylococcal enterotoxin B
  • Host Species
  • Mouse
  • Derivation
  • Mouse
  • Type
  • IgG
  • Specificity
  • Tested positive against native S. aureus SEB
  • Species Reactivity
  • S. aureus
  • Clone
  • 20B1
  • Applications
  • ELISA, Inhib, Neut, FuncS

Product Property

  • Purity
  • >95% by SDS-PAGE and HPLC analysis
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

Applications

  • Application Notes
  • The antibody was validated for Inhibition, ELISA and Function Assay. For details, refer to Published Data.

Target

  • Alternative Names
  • SEB; Staphylococcal enterotoxin B; enterotoxin type B

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 20B1"

See other products for "SEB"

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for PABL-337. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare